Furthermore, REMFS reverses PTMs that impair the normal function of IDPs, such as HSF1 and autophagy proteins, resulting in improved protein degradation, delayed aging [165], and potentially beneficial as an anti-amyloid therapy for human AD and neurodegenerative diseases [264]. The gene discussed is HSF1; the disease is amyloidosis.